Novel methods for identifying improved, non-sedating alpha-2 agonists
The present invention provides methods of preventing or alleviating sympathetically-enhanced conditions, neurological conditions, ocular conditions and chronic pain without concomitant sedation by peripherally administering to a subject an effective amoun
-
Page/Page column 18-19
(2008/06/13)
Nonsedating alpha-2 agonists
The present invention provides an α-2A/α-1A selective agonist that includes a compound represented by Structure 1 or a pharmaceutically acceptable salt, ester, amide, sterioisomer or racemic mixture thereof. The present invention further provides a pharma
-
Page/Page column 8
(2008/06/13)
More Articles about upstream products of 847829-38-3